Consumer Genomics

GSK and 23andMe Agree to $300M Deal

Pharmaceutical giant GlaxoSmithKline has bought a $300 million stake in genetic DTC testing company 23andMe to help further their genetics-based drug discovery.

Weekend Reads

This week: Are the conclusion about ‘alien’ mummy, Ata correct? Where is the African DNA in the search for cures? And is it possible to bury family secrets in the age of DNA testing? 

Weekend Reads

This week: Reversed ageing, pig organs, the future of humankind and citizen scientists using genetics to solve past crimes. 

Weekend Reads

What should doctors do when patients are pushing hard to get treatment they’ve seen in a TV ad or read about online? Why are diverse labs winning at science, and what went down at this year’s CRISPRcon?